Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (24.02.2026)
HOCH Abgang Schlüsselpersonen (20.02.2026)
HOCH Abgang Schlüsselpersonen (24.02.2026)
HOCH Abgang Schlüsselpersonen (20.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 24.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 20.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 25.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 14.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 06.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 01.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | and is incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; |
| 07.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 16.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 05.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | , 2023 are each incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Election of D |
| 02.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 26.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 15.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ch are incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; |
| 13.11.2023 | Item 1.03 — Insolvenz / Konkurs | KRITISCH | SEC | Item 1.03. Bankruptcy or Receivership. As previously disclosed, on August 28, 2023, Mallinckrodt plc (in examina |
| 10.10.2023 | Item 1.03 — Insolvenz / Konkurs | KRITISCH | SEC | nt Report on Form 8-K and incorporated into this Item 1.03 by reference. Capitalized terms used but not defined herein h |
| 28.08.2023 | Item 1.03 — Insolvenz / Konkurs | KRITISCH | SEC | Item 1.03. Bankruptcy or Receivership. As contemplated by the previously announced restructuring support agreeme |
| 07.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Com |
| 21.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C |
Stammdaten
Unternehmen & Branche
| Name | Keenova Therapeutics plc |
|---|---|
| Ticker | |
| CIK | 0001567892 |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 410,000 | 90.50 | 37,105,000.00 | +271,0% | |
| 2026-04-15 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 275,000 | 88.50 | 24,337,500.00 | +177,7% | |
| 2026-01-07 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 250,000 | 92.25 | 23,062,500.00 | +168,4% | |
| 2025-12-08 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 130,974 | 88.75 | 11,623,942.50 | +84,9% | |
| 2025-11-19 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 42,000 | 88.88 | 3,732,750.00 | +27,3% | |
| 2025-11-17 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 26,000 | 88.88 | 2,310,750.00 | +16,9% | |
| 2025-11-10 | Silver Point Capital L.P. | 10% Owner | Open Market Purchase | 290,000 | 93.75 | 27,187,500.00 | +198,6% | |
| 2025-08-06 | GOLDENTREE ASSET MANAGEMENT LP | 10% Owner | Open Market Purchase | 6,700 | 92.50 | 619,750.00 | +4,5% | |
| 2025-08-04 | GOLDENTREE ASSET MANAGEMENT LP | 10% Owner | Open Market Purchase | 30,000 | 87.25 | 2,617,500.00 | +19,1% | |
| 2025-08-01 | GOLDENTREE ASSET MANAGEMENT LP | 10% Owner | Open Market Purchase | 50,000 | 86.50 | 4,325,000.00 | +31,6% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.